Νοσοκομείο «Αλεξάνδρα»: Περισσότερες από 1.000 μεταμοσχεύσεις αρχέγονων αιμοποιητικών κυττάρων topontiki.gr/2025/05/07/nos…

Melbourne in May on Amyloidosis Day! Great workshop with Stathis The Australian Amyloidosis Network patients’ association is now led by Maureen & Garry Mahon (took over from the great Pat Neely). Loved catching up with Brendan, Olga and James. Thank you.

Sunshine in Sydney! Australian Amyloidosis Network Fiona Kwok you are a superstar! Great workshop catching up with Nikki Bart, Natasha Gorrie and Dan Chen. The Akubra hat suits you Stathis Thanks Oz!

Don’t miss our advanced online case study session where top experts unravel the most complex amyloidosis diagnoses. Starting in a couple of hours! 👉 Register now and join us soon! isaamyloidosis.org/2025-may-case-… #Amyloidosis #ISA_Amyloidosis #medicaleducation #CaseStudy

The amazing team from UK - National amyloidosis centre Royal Free London presenting annual clinical audit - over 1300 new amyloidosis patients seen last year with patient satisfaction over 97% highly positive - a beacon for rare diseases. A huge thanks to the whole team for an

Australian Amyloidosis Network Australia it’s been a blast! Brisbane did we maybe save the best till last?! Such impressive enthusiasm and energy for #amyloidosisawareness not least from the legend Pat Neely! Great to see Peter, Simon, Darius, Niri, Nicholas & James. Huge thanks to all.

Discontinuation of Len maint. 3 years post autoHCT with sustained BM and imaging MRD -ve status. N=52, 7-year PFS: 90%, 3-year treatment-free survival: 75.8% #mmsm #btsm Thanos Dimopoulos @BloodJournal ashpublications.org/blood/article/…

Right time: stopping multiple myeloma maintenance #mmsm #bmtsm Philip McCarthy Blood Journal ashpublications.org/blood/article/…

Now in @BloodJournal: congrats Thanos Dimopoulos et al on studying this prospectively! I love the abstract! Stopping len is a burning question for the #MMsm community and can also stop burning holes in our pocketbooks 💸 Good to see such great post-discontinuation PFS data here!

Suzanne Lentzsch receives the CoMy award for women’s achievement in MM very deserved and supported by her family and work colleagues

Gareth Morgan Richly deserved! You inspire us all Suzanne Lentzsch, MD, PhD

'Less is more' maintenance therapy in #MultipleMyeloma! Triplets→ASCT→3yr Len → D/C if MRD-neg (NGF+PET/CT-neg) Results: 3yr PFS ~93%, TFS ~75% *Treatment initiated for MRD resurgence Based on Ben Derman 's MRD2STOP + this data: I'm comfortable stopping Len in standard-risk

Great to be in Edinburgh for Peripheral Nerve Society 2025 talking about anti TTR amyloid antibodies and catching up with legend Prof Mary O’Reilly! Thanks for invite. #amyloidosisawareness

📢New paper alert in @BloodJournal We present BloodFlow, a method with an unprecedented sensitivity of 10-7 in myeloma. Another step towards meaningful assessment of #MRD in blood #mmsm Congrats Marta Carmen González Díaz-Cano PETHEMA Clínica Universidad de Navarra Cima Universidad de Navarra ashpublications.org/blood/article/…

Not all advances meet our hopes. Birtamimab, an anti-amyloid fibril agent, did not improve survival in the AFFIRM-AL trial for Mayo Stage IV AL amyloidosis. A disappointing result—but a clear reminder of the need for continued progress. BU Amyloidosis Center

Οι Καθηγητές Ευάγγελος Τέρπος και Μαρία Γαβριατοπούλου παρουσίασαν τις νεότερες κατευθυντήριες οδηγίες για το πολλαπλό μυέλωμα 2025 στο Ευρωπαϊκό Συνέδριο Αιματολογίας #EHA2025! Ο Διευθυντής Καθηγητής Θάνος Δημόπουλος είναι πρώτος συγγραφέας των νέων οδηγιών Thanos Dimopoulos 

#EHA2025 lifetime achievement award to Jesús San Miguel; my boss, mentor, friend, wedding planner and second-father! 18 years ago I was blessed by start working under his leadership, and I'm looking forward to the next 18 years! #mmsm Clínica Universidad de Navarra Cima Universidad de Navarra @sehh_es PETHEMA

Honored to be named a 2025 Hematology Research All-Star! This recognition by @Avant-garde Health highlights the top 5% of physicians for impactful research. Grateful to my collaborators and mentors, this is a shared achievement! BU Amyloidosis Center Boston Medical Center Boston U Chobanian & Avedisian School of Medicine

Save the date for the the 2026 International Symposium on Amyloidosis! Join leading clinicians, researchers, and scientists from around the globe at the premier meeting dedicated to amyloidosis and protein-folding diseases. Stay tuned for more details: isaamyloidosis.org/isa-symposium/

Determinants of 15-year progression-free survival in multiple #myeloma; real-world data from a single institution doi.org/10.1002/ajh.70… JohnNtan Despina Fotiou